Zinc blocks the intestinal absorption of copper from the diet and the reabsorption of endogenously secreted copper. Galzin ® (zinc acetate capsules) is now available for maintenance treatment of ...
Oppenheimer has initiated Monopar Therapeutics at outperform citing the potential of a candidate for the genetic disorder Wilson disease it acquired from AstraZeneca (AZN). The firm set a $77 price ...
Eton Pharmaceuticals has launched Galzin® (zinc acetate) capsules, the only FDA-approved zinc therapy for Wilson disease patients who have previously been treated with a chelating agent. To enhance ...
In another example of the effect of modifier genes, Schiefermeier et al [45] tried to delineate why some patients have later-onset neurologic as well as hepatic symptoms by examining the potential ...
Innorna Co. Ltd.’s investigational mRNA therapy, IN-013, has been awarded orphan drug and rare pediatric disease designations by the FDA for the treatment of Wilson disease.
Following liver transplantation, analysis of the explanted liver revealed extensive fibrosis and copper deposition. Wilson disease (WD), though primarily a hepatic and neurologic disorder, can cause ...
WILMETTE, Ill., Nov. 09, 2025 (GLOBE NEWSWIRE) -- Monopar Therapeutics Inc. (“Monopar” or the “Company”) (Nasdaq: MNPR), a clinical-stage biopharmaceutical company developing innovative treatments for ...
Research seems to be gaining ground in Wilson disease, a rare inherited condition that causes copper levels to accumulate in the liver, brain and eyes. Most people are diagnosed as children or around ...
The US Food and Drug Administration (FDA) has granted rare paediatric disease and orphan drug designations for IN013, Innorna's mRNA therapeutic for Wilson's disease. China-headquartered Innorna will ...
Good day, and thank you for standing by. Welcome to the Prime Medicine Wilson Disease KOL Event Conference Call. [Operator Instructions] Please be advised that today's conference is being recorded. I ...
Richard Rosencrantz, M.D.; Michael Schilsky, M.D. On physical exam, patients early on may have hepatomegaly, and over time may be seen to develop signs of chronic liver injury and cirrhosis with ...